EGF Theramed Health EBIT

EGF Theramed Health (TMED.CN) currently reports a EBIT of $-2.2M as of December 2025. That compares with $-410K in the prior-year period — down 434.2% year over year. That is below the sector sector average of $2.6T. Use the charts on this page to explore EGF Theramed Health's EBIT history and peer comparisons.

EGF Theramed Health's EBIT decreased from $-410K to $-2.2M — a 434.2% year-over-year decrease (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

EGF Theramed Health's EBIT of $-2.2M is lower than the its sector sector average of $2.6T. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

EGF Theramed Health reported $-2.2M in EBIT as of December 2025. That compares with $-410K in the prior-year period — down 434.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $-2.2M, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is $2.6T. From there, open related valuation or income-statement pages for EGF Theramed Health, and consider following TMED.CN for alerts when major investors trade the stock.